A UK feasibility and validation study of the VE1 monoclonal antibody immunohistochemistry stain for BRAF-V600E mutations in metastatic melanoma

被引：0
|
作者：
Michelle Chin I Lo
Anna Paterson
Jane Maraka
Richard Clark
Joseph Goodwill
Jenny Nobes
Jennifer Garioch
Marc Moncrieff
Ed Rytina
Laszlo Igali
机构：
[1] Norfolk and Norwich University Hospitals NHS Foundation Trust,Department of Plastic and Reconstructive Surgery
[2] Cambridge University Hospitals NHS Foundation Trust,Department of Histopathology (Box 235)
[3] Norfolk and Norwich University Hospitals NHS Foundation Trust,Department of Cellular Pathology
[4] Norfolk and Norwich University Hospitals NHS Foundation Trust,Department of Clinical Oncology
[5] Norwich Medical School,Department of Dermatology
[6] University of East Anglia,undefined
[7] Norfolk and Norwich University Hospitals NHS Foundation Trust,undefined
来源：
British Journal of Cancer | 2016年 / 115卷
关键词：
BRAF V600 mutation; melanoma; VE1 monoclonal antibody; immunohistochemistry;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：223 / 227
页数：4
相关论文
共 50 条
  • [1] A UK feasibility and validation study of the VE1 monoclonal antibody immunohistochemistry stain for BRAF-V600E mutations in metastatic melanoma
    Lo, Michelle Chin I.
    Paterson, Anna
    Maraka, Jane
    Clark, Richard
    Goodwill, Joseph
    Nobes, Jenny
    Garioch, Jennifer
    Moncrieff, Marc
    Rytina, Ed
    Igali, Laszlo
    BRITISH JOURNAL OF CANCER, 2016, 115 (02) : 223 - 227
  • [2] A UK Feasibility and Validation Study of the VE1 Monoclonal Antibody Immunohistochemistry Stain for BRAF V600 Mutations in Metastatic Melanoma Patients
    Maraka, J.
    Lo, M.
    Igali, L.
    Moncrieff, M.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S121 - S122
  • [3] Detection of BRAF V600E mutations in skin metastases of malignant melanoma by monoclonal antibody VE1
    Skorokhod, Alexander
    Capper, David
    von Deimling, Andreas
    Enk, Alexander
    Helmbold, Peter
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 67 (03) : 488 - 491
  • [4] Validation of the VE1 immunostain for the BRAF V600E mutation in melanoma
    Pearlstein, Michelle V.
    Zedek, Daniel C.
    Ollila, David W.
    Treece, Amanda
    Gulley, Margaret L.
    Groben, Pamela A.
    Thomas, Nancy E.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2014, 41 (09) : 724 - 732
  • [5] Immunohistochemical detection of the BRAF V600E mutation in melanoma patients with monoclonal antibody VE1
    Liu, Hui
    Li, Zhongwu
    Wang, Yan
    Feng, Qin
    Si, Lu
    Cui, Chuanliang
    Guo, Jun
    Xue, Weicheng
    PATHOLOGY INTERNATIONAL, 2014, 64 (12) : 601 - 606
  • [6] VE1 Is a Sensitive and Specific Marker for BRAF V600E Mutations in Melanoma
    Foreman, R. K.
    Sholl, L. M.
    Barletta, J. A.
    Hornick, J. L.
    LABORATORY INVESTIGATION, 2013, 93 : 114A - 114A
  • [7] VE1 Is a Sensitive and Specific Marker for BRAF V600E Mutations in Melanoma
    Foreman, R. K.
    Sholl, L. M.
    Barletta, J. A.
    Hornick, J. L.
    MODERN PATHOLOGY, 2013, 26 : 114A - 114A
  • [8] SENSITIVITY OF IMMUNOHISTOCHEMISTRY WITH BRAF VE1 ANTIBODY FOR BRAF V600E IN PRIMARY CENTRAL NERVOUS SYSTEM TUMORS
    Blaquier, Juan
    Egea, Sophie
    Gultekin, Sakir
    D'Angelo, Fulvio
    Iavarone, Antonio
    de la Fuente, Macarena
    NEURO-ONCOLOGY, 2024, 26
  • [9] VE1 immunohistochemistry in pituitary adenomas is not associated with BRAF V600E mutation
    Sperveslage, Jan
    Gierke, Midea
    Capper, David
    Honegger, Juergen
    Sipos, Bence
    Beschorner, Rudi
    Schittenhelm, Jens
    ACTA NEUROPATHOLOGICA, 2013, 125 (06) : 911 - 912
  • [10] VE1 immunohistochemistry in pituitary adenomas is not associated with BRAF V600E mutation
    Jan Sperveslage
    Midea Gierke
    David Capper
    Jürgen Honegger
    Bence Sipos
    Rudi Beschorner
    Jens Schittenhelm
    Acta Neuropathologica, 2013, 125 : 911 - 912
12345